Allergan (AGN) Affirms Receipt of FDA Committee Backing for Desmopressin Nasal Spray NDA
Tweet Send to a Friend
Allergan plc (NYSE: AGN) and Serenity Pharmaceuticals, LLC, announced that the US Food and Drug Administration (FDA) Bone, Reproductive and ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE